Marker Therapeutics Inc
MRKR
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.3M
Close$
Compare to Similar Companies
| P/E Ratio | Dividends | Return on Equity | Price-to-Sales | Debt-to-Equity | ||
|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | -2.3 | - | -88167989% | - | 0.1 | |
$1.05
27.1% downside
Current Fair Value
27.1% downsideOvervalued by 27.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.30 Million |
|---|---|
| Enterprise Value | $2.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.79 |
| Beta | 1.45 |
| Outstanding Shares | 19,314,742 |
Return
| Return on Equity | -88167989.01% |
|---|---|
| Return on Assets | -69769491.52% |
| Return on Invested Capital | -93436247.52% |
Valuation & Multiples
| P/E Ratio | -2.25 |
|---|---|
| PEG | 7.91 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.66 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
$682,100
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$682,100
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 25.49% |
|---|---|
| Total Invested | $107▼ 100.00% |
| Investors Holding | 1▼ 35.00% |
ESG Score
No data
About Marker Therapeutics Inc
CEO: Peter Hoang